These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15076289)

  • 1. Complications of post-chemotherapy retroperitoneal lymph node dissection for testis cancer.
    Mosharafa AA; Foster RS; Koch MO; Bihrle R; Donohue JP
    J Urol; 2004 May; 171(5):1839-41. PubMed ID: 15076289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
    Heidenreich A; Albers P; Hartmann M; Kliesch S; Kohrmann KU; Krege S; Lossin P; Weissbach L;
    J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity?
    Mosharafa AA; Foster RS; Leibovich BC; Bihrle R; Johnson C; Donohue JP
    J Urol; 2003 Jun; 169(6):2126-8. PubMed ID: 12771733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
    Rassweiler JJ; Scheitlin W; Heidenreich A; Laguna MP; Janetschek G
    Eur Urol; 2008 Nov; 54(5):1004-15. PubMed ID: 18722704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial impact of a clinical care pathway in patients with testicular cancer undergoing retroperitoneal lymph node dissection.
    Chang SS; Smith JA; Girasole C; Baumgartner RG; Roth BJ; Cookson MS
    J Urol; 2002 Jul; 168(1):87-92. PubMed ID: 12050498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer.
    Coogan CL; Hejase MJ; Wahle GR; Foster RS; Rowland RG; Bihrle R; Donohue JP
    J Urol; 1996 Nov; 156(5):1656-8. PubMed ID: 8863564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of laparoscopic retroperitoneal lymph node dissection: a single-center 10-year experience.
    Steiner H; Peschel R; Janetschek G; Höltl L; Berger AP; Bartsch G; Hobisch A
    Urology; 2004 Mar; 63(3):550-5. PubMed ID: 15028456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morbidity of open retroperitoneal lymph node dissection for testicular cancer: contemporary perioperative data.
    Williams SB; McDermott DW; Winston D; Bahnson E; Berry AM; Steele GS; Richie JP
    BJU Int; 2010 Apr; 105(7):918-21. PubMed ID: 19747353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications of open primary and post-chemotherapy retroperitoneal lymph node dissection for testicular cancer.
    Subramanian VS; Nguyen CT; Stephenson AJ; Klein EA
    Urol Oncol; 2010; 28(5):504-9. PubMed ID: 19097812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion.
    Stephenson AJ; Bosl GJ; Bajorin DF; Stasi J; Motzer RJ; Sheinfeld J
    J Urol; 2005 Aug; 174(2):557-60; discussion 560. PubMed ID: 16006891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term morbidity of primary retroperitoneal lymph node dissection in a contemporary group of patients.
    Beck SD; Peterson MD; Bihrle R; Donohue JP; Foster RS
    J Urol; 2007 Aug; 178(2):504-6; discussion 506. PubMed ID: 17561131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors.
    Eggener SE; Carver BS; Loeb S; Kondagunta GV; Bosl GJ; Sheinfeld J
    Cancer; 2007 Feb; 109(3):528-35. PubMed ID: 17177200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
    Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP
    J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. En bloc nephrectomy in patients undergoing post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous testis cancer: indications, implications and outcomes.
    Nash PA; Leibovitch I; Foster RS; Bihrle R; Rowland RG; Donohue JP
    J Urol; 1998 Mar; 159(3):707-10. PubMed ID: 9474130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of bilateral nerve sparing laparoscopic retroperitoneal lymph node dissection for testicular cancer.
    Steiner H; Zangerl F; Stöhr B; Granig T; Ho H; Bartsch G; Peschel R
    J Urol; 2008 Oct; 180(4):1348-52; discussion 1352-3. PubMed ID: 18707723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified and bilateral retroperitoneal lymph node dissection for testicular cancer: peri- and postoperative complications and therapeutic outcome.
    Tanaka T; Kitamura H; Kunishima Y; Takahashi S; Takahashi A; Masumori N; Itoh N; Tsukamoto T
    Jpn J Clin Oncol; 2006 Jun; 36(6):381-6. PubMed ID: 16762970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.
    Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN
    J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aortic replacement during post-chemotherapy retroperitoneal lymph node dissection.
    Beck SD; Foster RS; Bihrle R; Koch MO; Wahle GR; Donohue JP
    J Urol; 2001 May; 165(5):1517-20. PubMed ID: 11342909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does retroperitoneal lymph node dissection have a curative role for patients with sex cord-stromal testicular tumors?
    Mosharafa AA; Foster RS; Bihrle R; Koch MO; Ulbright TM; Einhorn LH; Donohue JP
    Cancer; 2003 Aug; 98(4):753-7. PubMed ID: 12910519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeat retroperitoneal lymph node dissection for metastatic testis cancer.
    Sexton WJ; Wood CG; Kim R; Pisters LL
    J Urol; 2003 Apr; 169(4):1353-6. PubMed ID: 12629359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.